Osteoporosis: protecting bone mass with fundamentals and drug therapy

Agonist activity of the 3-hydroxy metabolites of tibolone through the oestrogen receptor in the mouse N20.1 oligodendrocyte cell line and normal human astrocytes.

Journal of neuroendocrinology·2007

Osteoporosis prevention and therapy: preserving and building strength through bone quality.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2006

The challenges of peripheral bone density testing: which patients need additional central density skeletal measurements?

Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry·2004

Prevalence of osteoporosis in women referred for bone density testing: utility of multiple skeletal sites.

Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry·2004

Importance of precision in bone density measurements.

Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry·2001

Excretion of sweat and urine pyridinoline crosslinks in healthy controls and subjects with established metabolic bone disease.

Clinical chemistry and laboratory medicine·2001

Opioid receptor agonist-antagonists in pain management: receptor specific mechanisms, dose response relationships, and clinical combination strategies.

Frontiers in pain research (Lausanne, Switzerland)·2026

Characteristics and Hospitalization Details of Patients with Advanced Parkinson's Disease Receiving Continuous Subcutaneous Infusion of Foslevodopa/Foscarbidopa: Real-World First-Year Descriptive Study from Japan.

Neurology and therapy·2026

Clinical Use of Aripiprazole Monohydrate Long-Acting Injectable in Adolescents: A Case Series and Review of the Literature.

International journal of psychiatry in medicine·2026

Related Experiment Videos

Osteoporosis: protecting bone mass with fundamentals and drug therapy

Related Concept Videos

Agonist activity of the 3-hydroxy metabolites of tibolone through the oestrogen receptor in the mouse N20.1 oligodendrocyte cell line and normal human astrocytes.

Osteoporosis prevention and therapy: preserving and building strength through bone quality.

The challenges of peripheral bone density testing: which patients need additional central density skeletal measurements?

Prevalence of osteoporosis in women referred for bone density testing: utility of multiple skeletal sites.

Importance of precision in bone density measurements.

Excretion of sweat and urine pyridinoline crosslinks in healthy controls and subjects with established metabolic bone disease.

Dupilumab for Drug-Induced Bullous Pemphigoid: A Case Series and Literature Review.

Effect of amlodipine and telmisartan on bone metabolism markers in newly diagnosed hypertensive patients.

Spatial pharmacology of anti-cancer immunomodulators: a comprehensive review.

Opioid receptor agonist-antagonists in pain management: receptor specific mechanisms, dose response relationships, and clinical combination strategies.

Characteristics and Hospitalization Details of Patients with Advanced Parkinson's Disease Receiving Continuous Subcutaneous Infusion of Foslevodopa/Foscarbidopa: Real-World First-Year Descriptive Study from Japan.

Clinical Use of Aripiprazole Monohydrate Long-Acting Injectable in Adolescents: A Case Series and Review of the Literature.

Related Experiment Videos

Osteoporosis: protecting bone mass with fundamentals and drug therapy

Related Concept Videos

Related Articles